Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31160
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCORRAL, Marcelo Andreetta
dc.contributor.authorPAULA, Fabiana Martins de
dc.contributor.authorMEISEL, Dirce Mary C. L.
dc.contributor.authorABDALA, Edson
dc.contributor.authorCOSTA, Silvia Figueiredo
dc.contributor.authorPIERROTTI, Ligia Camera
dc.contributor.authorYAMASHIRO, Juliana
dc.contributor.authorGONCALVES, Elenice M. do Nascimento
dc.contributor.authorCASTILHO, Vera Lucia P.
dc.contributor.authorCHIEFFI, Pedro Paulo
dc.contributor.authorGRYSCHEK, Ronald Cesar B.
dc.date.accessioned2019-03-26T14:29:34Z
dc.date.available2019-03-26T14:29:34Z
dc.date.issued2019
dc.identifier.citationACTA TROPICA, v.190, p.357-360, 2019
dc.identifier.issn0001-706X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31160
dc.description.abstractImmunocompromised patients constitute a risk group for the development of severe clinical forms of human strongyloidiasis. The diagnosis of this infection is primarily performed by parasitological techniques, but with low sensitivity. Serological techniques appear as an alternative, especially with heterologous antigens use. The aim of this study was to perform the Western blot technique by using S. venezuelensis infective third stage larva (iL3) soluble (TS) and membrane (TM) saline antigens to reveal immunoreactive bands in immunocompromised patients with strongyloidiasis. Serum samples from 117 parasitologically well-characterized patients were divided into four groups: S. stercoralis positive and immunocompetent (S + IC); S. stercoralis positive and immunocompromised (S + IP); negative and immunocompetent (S-IC); negative and immunocompromised (S-IP). A 40-35 kDa band was recognized by 100% of patients in the S + IC group in both antigenic fractions, and by 62.5% and 50% in the S + IP group using the TS and TM fractions, respectively. A 29 kDa band was recognized by 86.3% and 72.7% (for TS and TM, respectively) of patients in the S + IC group, and only by 12.5% of patients in the S + IP group on the TM antigen. Regardless of the patients' immunological condition, the 40-35 kDa band from S. venezuelensis was detected more frequently and can be used as an important marker to the immunodiagnosis of human strongyloidiasis.eng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2010/51110-2, 2013/04236-9]
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BVeng
dc.relation.ispartofActa Tropica
dc.rightsrestrictedAccesseng
dc.subjectStrongyloides venezuelensiseng
dc.subject40-35 kDa bandeng
dc.subjectImmunocompromised patientseng
dc.subject.otherhuman infectionseng
dc.subject.otherstercoraliseng
dc.subject.otherdiagnosiseng
dc.subject.otherimmunodiagnosiseng
dc.subject.otheridentificationeng
dc.subject.otherproteinseng
dc.subject.otherserumeng
dc.titleIgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patientseng
dc.typearticleeng
dc.rights.holderCopyright ELSEVIER SCIENCE BVeng
dc.identifier.doi10.1016/j.actatropica.2018.12.020
dc.identifier.pmid30552879
dc.subject.wosParasitologyeng
dc.subject.wosTropical Medicineeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.description.beginpage357
hcfmusp.description.endpage360
hcfmusp.description.volume190
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000457510400053
hcfmusp.origem.id2-s2.0-85058438555
hcfmusp.publisher.cityAMSTERDAMeng
hcfmusp.publisher.countryNETHERLANDSeng
hcfmusp.relation.referenceArifin N, 2018, AM J TROP MED HYG, V98, P1165, DOI 10.4269/ajtmh.17-0697eng
hcfmusp.relation.referenceBatista MV, 2011, TROP MED INT HEALTH, V16, P1134, DOI 10.1111/j.1365-3156.2011.02816.xeng
hcfmusp.relation.referenceBosqui LR, 2015, ACTA TROP, V150, P190, DOI 10.1016/j.actatropica.2015.07.026eng
hcfmusp.relation.referenceCONWAY DJ, 1993, J INFECT DIS, V168, P784, DOI 10.1093/infdis/168.3.784eng
hcfmusp.relation.referenceCorral MA, 2017, PARASITOLOGY, V144, P124, DOI 10.1017/S0031182016001645eng
hcfmusp.relation.referenceCorral MA, 2015, REV INST MED TROP SP, V57, P77, DOI 10.1590/S0036-46652015000100011eng
hcfmusp.relation.referenceCosta-Cruz Julia Maria, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P265, DOI 10.1590/S0036-46652003000500005eng
hcfmusp.relation.referenceCunha RA, 2017, PARASITOL INT, V66, P671, DOI 10.1016/j.parint.2017.07.001eng
hcfmusp.relation.referenceDitgen D, 2018, MOL BIOCHEM PARASIT, V225, P73, DOI 10.1016/j.molbiopara.2018.08.008eng
hcfmusp.relation.referenceFardet L, 2006, CLIN MICROBIOL INFEC, V12, P945, DOI 10.1111/j.1469-0691.2006.01443.xeng
hcfmusp.relation.referenceGarcia LS, 2001, DIAGNOSTIC MED PARASeng
hcfmusp.relation.referenceGonzaga HT, 2011, IMMUNOL LETT, V139, P87, DOI 10.1016/j.imlet.2011.05.006eng
hcfmusp.relation.referenceGrove DI, 1996, ADV PARASIT, V38, P251, DOI 10.1016/S0065-308X(08)60036-6eng
hcfmusp.relation.referenceGuerrero-Wooley R, 2017, AM J TROP MED HYG, V97, P1629, DOI 10.4269/ajtmh.17-0492eng
hcfmusp.relation.referenceInes ED, 2013, DIAGN MICR INFEC DIS, V76, P31, DOI 10.1016/j.diagmicrobio.2013.01.016eng
hcfmusp.relation.referenceKOGA K, 1991, AM J TROP MED HYG, V45, P518, DOI 10.4269/ajtmh.1991.45.518eng
hcfmusp.relation.referenceLevenhagen MA, 2014, ACTA TROP, V135, P33, DOI 10.1016/j.actatropica.2014.03.015eng
hcfmusp.relation.referenceMachado ER, 2008, EXP PARASITOL, V119, P7, DOI 10.1016/j.exppara.2007.12.008eng
hcfmusp.relation.referenceOlsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013eng
hcfmusp.relation.referenceRequena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002eng
hcfmusp.relation.referenceRodpai R, 2017, PARASITOL RES, V116, P1687, DOI 10.1007/s00436-017-5443-9eng
hcfmusp.relation.referenceRodpai R, 2016, PARASITOL RES, V115, P4007, DOI 10.1007/s00436-016-5170-7eng
hcfmusp.relation.referenceSiddiqui AA, 1997, PARASITOL RES, V83, P655, DOI 10.1007/s004360050314eng
hcfmusp.relation.referenceSilva LP, 2003, MEM I OSWALDO CRUZ, V98, P687, DOI 10.1590/S0074-02762003000500017eng
hcfmusp.relation.referenceSilva MLS, 2016, ACTA TROP, V154, P133, DOI 10.1016/j.actatropica.2015.11.010eng
hcfmusp.relation.referenceTeixeira MCA, 2016, BIOMED RES INT, DOI 10.1155/2016/4872473eng
hcfmusp.relation.referenceToledo R, 2015, ADV PARASIT, V88, P165, DOI 10.1016/bs.apar.2015.02.005eng
hcfmusp.relation.referenceUparanukraw P, 1999, AM J TROP MED HYG, V60, P967, DOI 10.4269/ajtmh.1999.60.967eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1873-6254
hcfmusp.citation.scopus5
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Artigos e Materiais de Revistas Científicas - FM/MPR
Departamento de Medicina Preventiva - FM/MPR

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/03
LIM/03 - Laboratório de Medicina Laboratorial

Artigos e Materiais de Revistas Científicas - LIM/06
LIM/06 - Laboratório de Imunopatologia da Esquistossomose e outras Parasitoses

Artigos e Materiais de Revistas Científicas - LIM/37
LIM/37 - Laboratório de Transplante e Cirurgia de Fígado

Artigos e Materiais de Revistas Científicas - LIM/49
LIM/49 - Laboratório de Protozoologia


Files in This Item:
File Description SizeFormat 
art_CORRAL_IgG_reactivity_with_4035_kDa_soluble_and_membrane_2019.PDF
  Restricted Access
publishedVersion (English)392.28 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.